| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Annals of Surgical Oncology, Vol 6, Issue 1 88-94, Copyright © 1999 by Society of Surgical Oncology
ARTICLES |
R. P. DeMatteo, H. Yeh, M. Friscia, D. Caparrelli, C. Burke, N. Desai, G. Chu, J. F. Markmann, S. E. Raper and C. F. Barker
Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, USA.
BACKGROUND: Adenoviral gene therapy is a promising new approach for the treatment of neoplastic diseases. To design rational clinical trials and distinguish the effects of therapeutic transgene expression from those caused by viral infection alone, the immune response to the vector must be understood. In these experiments, we further define cellular immunity to recombinant adenovirus. METHODS: The immune response to hepatic adenoviral gene transfer was studied in infected mice by depleting T cells with an anti-CD3 antibody, measuring splenocyte cytokine production, determining the impact of transgene expression on inflammation, and assessing liver MHC protein expression. RESULTS: The cellular immune response to recombinant adenovirus is (1) averted by T lymphocyte depletion, (2) marked by a TH1 response with increased IL-2 production, (3) directed against both the transgene product and viral proteins, and (4) associated with increased hepatocyte MHC Class I expression. CONCLUSIONS: It is necessary to take into consideration the constraints imposed by the immunogenicity of recombinant adenovirus and its transient transgene expression in the clinical application of adenoviral gene transfer for the treatment of cancer.
This article has been cited by other articles:
![]() |
K. I. Kim, J. H. Kang, J.-K. Chung, Y. J. Lee, J. M. Jeong, D. S. Lee, and M. C. Lee Doxorubicin Enhances the Expression of Transgene Under Control of the CMV Promoter in Anaplastic Thyroid Carcinoma Cells J. Nucl. Med., September 1, 2007; 48(9): 1553 - 1561. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Brandsma, M. Shlyankevich, L. Zhang, M. D. Slade, E. C. Goodwin, W. Peh, and A. B. Deisseroth Vaccination of Rabbits with an Adenovirus Vector Expressing the Papillomavirus E2 Protein Leads to Clearance of Papillomas and Infection J. Virol., January 1, 2004; 78(1): 116 - 123. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kojima, M. Iida, H. Miyazaki, T. Koga, H. Moriyama, and Y. Manome Enhancement of Cytarabine Sensitivity in Squamous Cell Carcinoma Cell Line Transfected With Deoxycytidine Kinase Arch Otolaryngol Head Neck Surg, June 1, 2002; 128(6): 708 - 713. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. D. Tran, C. D. Porada, G. Almeida-Porada, H. A. Glimp, W. F. Anderson, and E. D. Zanjani Induction of stable prenatal tolerance to {beta}-galactosidase by in utero gene transfer into preimmune sheep fetuses Blood, June 1, 2001; 97(11): 3417 - 3423. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Budts, P. Pokreisz, Z. Nong, N. Van Pelt, H. Gillijns, R. Gerard, R. Lyons, D. Collen, K. D. Bloch, and S. Janssens Aerosol Gene Transfer With Inducible Nitric Oxide Synthase Reduces Hypoxic Pulmonary Hypertension and Pulmonary Vascular Remodeling in Rats Circulation, December 5, 2000; 102(23): 2880 - 2885. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. W. Tillman, T. L. Hayes, T. D. deGruijl, J. T. Douglas, and D. T. Curiel Adenoviral Vectors Targeted to CD40 Enhance the Efficacy of Dendritic Cell-based Vaccination against Human Papillomavirus 16-induced Tumor Cells in a Murine Model Cancer Res., October 1, 2000; 60(19): 5456 - 5463. [Abstract] [Full Text] |
||||
![]() |
D. T. Curiel The Development of Conditionally Replicative Adenoviruses for Cancer Therapy Clin. Cancer Res., September 1, 2000; 6(9): 3395 - 3399. [Abstract] [Full Text] |
||||
![]() |
P. R. Dash, M. L. Read, K. D. Fisher, K. A. Howard, M. Wolfert, D. Oupicky, V. Subr, J. Strohalm, K. Ulbrich, and L. W. Seymour Decreased Binding to Proteins and Cells of Polymeric Gene Delivery Vectors Surface Modified with a Multivalent Hydrophilic Polymer and Retargeting through Attachment of Transferrin J. Biol. Chem., February 11, 2000; 275(6): 3793 - 3802. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |